Author:
Takahata Kaori,Horiuchi Shigeko,Miyauchi Ai,Tadokoro Yuriko,Shuo Takuya
Abstract
AbstractBreastfeeding is known to improve maternal and child health. However, epidural anesthesia (EDA) and synthetic oxytocin (synOT) are suggested to have negative effects on breastfeeding. In this study, we aimed to determine the effects of intrapartum synOT and EDA on breast milk supply, breastfeeding rates, and maternal salivary oxytocin levels. Women were recruited during pregnancy or after birth at a single hospital. Data were collected at 3 days postpartum (T1), 1 month postpartum (T2), and 4 months postpartum (T3) on 83 low-risk primiparous women who planned to breastfeed for at least 12 weeks postpartum to avoid dropouts from early discontinuance of breastfeeding. Women with cesarean section, twin pregnancy, premature neonates, and an Apgar score of < 7 at 5 min were excluded. Participants recorded their 24-h milk supply by test weights at 3 days and 1 month postpartum. Additionally, they filled out questionnaires assessing their breastfeeding level and lactogenesis stage II initiation. Salivary oxytocin levels were obtained at 3 days postpartum. Women who delivered using EDA had lower salivary oxytocin levels (P = .055, d = .442), breast milk supply in early postpartum (P = .025, d = .520) and at 1 month postpartum (P = .036, d = .483), and breastfeeding rates at 4 months postpartum (P = .037, V = .236) than women who did not deliver using EDA. There was no association between breastfeeding and the use of intrapartum synOT. In conclusion, this study showed that women who delivered using EDA had lower breast milk supply in the early postpartum period and breastfeeding rates at 4 months postpartum. It also revealed that using synOT at low doses during labor did not affect breastfeeding. Thus, women who deliver using EDA need support for increased breast milk supply in the early postpartum period.Trial registration: UMIN000037783 (Clinical Trials Registry of University Hospital Information Network).
Funder
Pigeon Corporation
Pfizer Health Research Foundation
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Kenyon, S., Tokumasu, H., Dowswell, T., Pledge, D. & Mori, R. High-dose versus low-dose oxytocin for augmentation of delayed labour. Cochrane Database Syst. Rev. 7, CD007201 (2013).
2. Patka, J. H., Lodolce, A. E. & Johnston, A. K. High- versus low-dose oxytocin for augmentation or induction of labor. Ann. Pharmacother. 39(1), 95–101 (2005).
3. Tesemma, M. G., Sori, D. A. & Gemeda, D. H. High dose and low dose oxytocin regimens as determinants of successful labor induction: A multicenter comparative study. BMC Pregnancy Childbirth 20(1), 232–234 (2020).
4. Budden, A., Chen, L. J. Y. & Henry, A. High-dose versus low-dose oxytocin infusion regimens for induction of labour at term. Cochrane Database Syst. Rev. 2014(10), CD009701 (2014).
5. Uvnäs Moberg, K. et al. Maternal plasma levels of oxytocin during breastfeeding—A systematic review. PLOS ONE 15(8), e0235806 (2020).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献